Welcome to our dedicated page for D. Boral ARC Acquisition I SEC filings (Ticker: BCAR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on D. Boral ARC Acquisition I's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into D. Boral ARC Acquisition I's regulatory disclosures and financial reporting.
D. Boral ARC Acquisition I Corp. reported that shareholders approved all proposals related to its business combination with Exascale Labs Inc. at a July 29, 2026 extraordinary general meeting. Holders of 25,658,433 of 41,200,000 ordinary shares entitled to vote were present, representing 62.28% of shares.
Shareholders approved the Business Combination Agreement, the Domestication Merger from the British Virgin Islands to Delaware, and new organizational documents for the post-combination Delaware corporation. Upon domestication, PubCo will be renamed Exascale Labs Holdings Inc. They also approved advisory changes to authorized share structure and voting rights (including high-vote Class B), exclusive forum provisions, higher thresholds to amend certain charter provisions, director removal for cause with a 66⅔% vote, and the corporate name change.
Shareholders elected a five-member PubCo board with staggered terms, approved an Equity Incentive Plan, and authorized the issuance of PubCo common stock and warrants under Nasdaq Listing Rule 5635 in connection with the business combination. Public shareholders elected to redeem 26,865,211 Class A ordinary shares, representing 95.95% of outstanding public shares.
D. Boral ARC Acquisition I Corp. shareholders approved the business combination with Exascale Labs Inc., including the Acquisition Merger, a domestication from the British Virgin Islands to Delaware, and new organizational documents for the post‑closing company, to be named Exascale Labs Holdings Inc. Shareholders also approved six advisory governance changes, elected five directors with staggered terms, adopted an equity incentive plan, and approved the issuance of PubCo common stock and warrants under Nasdaq Listing Rule 5635.
Holders redeemed 26,865,211 Class A ordinary shares, representing 95.95% of outstanding public shares, leaving approximately $12 million in BCAR’s trust account, which satisfies the minimum cash closing condition. The combined company’s Class A common stock and warrants are expected to trade on Nasdaq under the symbols “XLAB” and “XLABW”. Exascale operates a next‑generation, asset‑light AI infrastructure platform focused on GPU‑as‑a‑Service and related data center solutions.
Exascale Labs, which is completing a Business Combination with D. Boral ARC Acquisition I Corp. (Nasdaq: BCAR), outlines progress on an estimated $300 million AI customer opportunity pipeline. The update highlights a non-binding MOU with RUTILEA for potential development and commercialization of up to 20MW of data center capacity, a recently announced $71.4 million agreement with Dimension AI creating a multi-year GPU-as-a-Service revenue opportunity, and a $53 million MOU with AI Nova for potential near-term AI infrastructure revenue. Exascale describes an asset-light, software-defined GPU compute and modular data center platform focused on large-scale AI workloads and reminds BCAR shareholders to review the Form S-4 registration statement and proxy statement/prospectus related to the proposed Business Combination.
Exascale Labs Inc., which is pursuing a Business Combination with D. Boral ARC Acquisition I Corp. (BCAR), entered a three-year Compute Service Agreement with Dimension AI Pte. Ltd. Under this agreement, Exascale will procure approximately US$71.4 million of dedicated GPU compute capacity to expand its GPU‑as‑a‑Service and token factory platform.
Exascale operates an asset‑light, software‑defined AI infrastructure platform for large‑scale workloads such as LLM training, fine‑tuning and high‑concurrency inference, and also offers modular data center and power solutions. After completion of the Business Combination, the combined company is expected to operate as Exascale Labs Holdings Inc., with Class A common stock expected to trade on Nasdaq under ticker “XLAB.”
D. Boral ARC Acquisition I Corp. furnished an 8-K reporting that the registrant and Exascale scheduled an Extraordinary General Meeting to vote on the previously announced Business Combination. The Meeting is set for July 29, 2026 at 10:00 AM Eastern Time. Shareholders of record as of July 6, 2026 are eligible to attend and vote. The Meeting will be held in person at Loeb & Loeb LLP in New York and virtually at www.proxydocs.com/BCAR. The filing states that a Registration Statement on Form S-4 (File No. 333-297214) has been filed and that the definitive proxy statement/prospectus has been mailed to shareholders.
D. Boral ARC Acquisition I Corp. (BCAR) has scheduled an Extraordinary General Meeting of shareholders for July 29, 2026 at 10:00 a.m. Eastern Time to vote on its previously announced business combination with Exascale Labs Inc.
Shareholders of record as of July 6, 2026 may attend and vote, either in person at Loeb & Loeb LLP in New York or virtually via proxydocs.com/BCAR. If approved and closing conditions are satisfied or waived, the combined company is expected to operate as Exascale Labs Holdings Inc. with its shares trading on Nasdaq under the ticker “XLAB.”
D. Boral ARC Acquisition I Corp. files a proxy statement/prospectus for a Business Combination that contemplates issuance of up to 60,456,000 shares of Class A Ordinary Common Stock, 30,744,000 shares of Class B Super Common Stock and 14,100,000 warrants.
The filing describes a merger agreement to combine BCAR (to be domesticated into Delaware and renamed Exascale Labs Holdings Inc.) with Exascale Labs Inc., under which 50,000,000 shares of PubCo Common Stock are allocated as merger consideration among Exascale securityholders. The proxy/prospectus discloses that as of July 6, 2026 BCAR’s trust account held $290,025,825.19, estimates a per-share redemption value of approximately $10.36 for the meeting, and sets an Extraordinary General Meeting for July 29, 2026. The BCAR Board and Insiders (owning ~32.0%) recommend approval; closing remains subject to customary conditions including receipt of a minimum cash financing and Nasdaq conditional listing.
D. Boral ARC Acquisition I Corp. is seeking shareholder approval to complete a business combination with Exascale Labs Inc. under an Agreement and Plan of Merger dated January 11, 2026. The merger consideration contemplates 50,000,000 shares of PubCo common stock to be issued at closing.
The transaction contemplates a domestication of BCAR into Delaware, issuance of dual-class PubCo stock, and a Minimum Cash Financing condition requiring PubCo to receive at least $5,000,000 before closing. An Extraordinary General Meeting is scheduled for July 29, 2026 (Record Date: July 6, 2026), and BCAR estimates a per-share redemption price of approximately $10.36 based on trust account balances.
D. Boral ARC Merger Corporation filed a preliminary proxy statement/prospectus on Form S-4 dated July 1, 2026 to effect a business combination with Exascale Labs Inc. The proxy/prospectus solicits shareholder approvals for the Business Combination, domestication to Delaware, organizational documents, director elections, an equity incentive plan and Nasdaq listing actions.
The proposed transaction contemplates issuance of 50,000,000 shares of PubCo Common Stock as merger consideration and a prospectus for up to 60,456,000 PubCo Class A shares, 30,744,000 PubCo Class B shares and 14,100,000 warrants (for issuance). Completion is conditioned on customary closing items, including a Minimum Cash Financing of $5,000,000, Nasdaq conditional listing approval, and requisite shareholder votes.